Assignee
PHARMABCINE INC
KR·9 granted patents·6 pending applications·10 citations·filing 2013–2023
Top patents by PatentIndex Score
15 records- 0187US10106622B2Human antibody specific to c-Met and preparation method thereofPHARMABCINE INC·Filed 2015·Granted Oct 23, 2018·9 cites·8 claims
- 0266US9963512B2Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including samePHARMABCINE INC·Filed 2013·Granted May 8, 2018·1 cites·4 claims
- 0366US9249219B2Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereofPHARMABCINE INC·Filed 2014·Granted Feb 2, 2016·0 cites·6 claims
- 0462US9249220B2Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereofPHARMABCINE INC·Filed 2014·Granted Feb 2, 2016·0 cites·6 claims
- 0556US2025179192A1Fusion protein comprising modified anti-vegfr2 (kdr) antibody and use thereofPHARMABCINE INC·Filed 2023·Application pending·0 cites
- 0655US2024383989A1Modified anti-vegfr2 (kdr) antibody and use thereofPHARMABCINE INC·Filed 2022·Application pending·0 cites
- 0754US2023265196A1Combination Therapy of a PD-1 Antagonist and an Antagonist for VEGFR-2 for Treating Patients with CancerPHARMABCINE INC·Filed 2021·Application pending·0 cites
- 0852US2023303675A1Modified antibody and method for manufacturing samePHARMABCINE INC·Filed 2021·Application pending·0 cites
- 0950US10155817B2Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including samePHARMABCINE INC·Filed 2018·Granted Dec 18, 2018·0 cites·8 claims
- 1047US10597457B2EGFRvIII antibody and composition comprising samePHARMABCINE INC·Filed 2014·Granted Mar 24, 2020·0 cites·9 claims
- 1145US2022204603A1Anti-ang2 antibody and use thereofPHARMABCINE INC·Filed 2020·Application pending·0 cites
- 1245US2021009695A1Anti-vegfr-2 antibodyPHARMABCINE INC·Filed 2019·Application pending·0 cites
- 1344US12473366B2Anti-TIE2 antibody and use thereofPHARMABCINE INC·Filed 2020·Granted Nov 18, 2025·0 cites·15 claims
- 1440US11407834B2Anti-PD-L1 antibody and use thereofPHARMABCINE INC·Filed 2018·Granted Aug 9, 2022·0 cites·9 claims
- 1539US11407833B2Anti-VISTA antibody and use thereofPHARMABCINE INC·Filed 2018·Granted Aug 9, 2022·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when PHARMABCINE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →